Cheng-jun Sui
Shanghai, 200441, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 10, 2023
Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 12, 2020
Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: August 04, 2019
Liver resection is justified for multinodular hepatocellular carcinoma in selected patients with cirrhosis: A multicenter analysis of 1,066 patients.
Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Published: September 27, 2018
lncARSR promotes liver cancer stem cells expansion via STAT3 pathway.
Journal: Gene
Published: September 10, 2018
Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: January 27, 2016
MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.
Journal: American journal of cancer research
Published: August 20, 2015
Last Updated: 09/26/2026